Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03043430 · ClinicalTrials.gov registry record · Phase 4
Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients
A Phase 4 study, sponsored by Brooke Army Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT03043430: Clinical Trial Phase 4 study, sponsored by Brooke Army Medical Center.
NCT03043430 is a Phase 4 study that was terminated before completion, run by Brooke Army Medical Center. The registered enrollment target is 10 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03043430, a Phase 4 study, was terminated before completion, sponsored by Brooke Army Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
Investigators plan to conduct a randomized, double-blinded, controlled study among pediatric patients requiring minor procedures in the Emergency Department setting. Patients will be randomized to one of two arms of intranasal treatments: ketamine 1.0 mg/kg (K) or midazolam 0.3 mg/kg (M). The primary outcome will be change in anxiety using the Modified Yale Preoperative Anxiety Scale (mYPAS).
Primary Outcome
Modified Yale preoperative anxiety scale
Interventions
- DRUG Ketamine 100 MG/ML
- DRUG Midazolam 5 MG/ML
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-05 |
| Est. Completion | 2023-04 |
| Phase | Phase 4 |
Why NCT03043430 stopped before completion
NCT03043430 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Ketamine 100 MG/ML is the first listed.
NCT03043430 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03043430 about?
NCT03043430 is a clinical study titled "Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients". Investigators plan to conduct a randomized, double-blinded, controlled study among pediatric patients requiring minor procedures in the Emergency Department setting. Patients will be randomized to one of two arms of intranasal treatments: ketamine 1.0 mg/kg (K) or midazolam 0.3 mg/kg (M). The primar...
What is the current status of trial NCT03043430?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2016-05. Estimated completion is 2023-04.
What interventions are being tested in trial NCT03043430?
The interventions under investigation include: Ketamine 100 MG/ML (DRUG), Midazolam 5 MG/ML (DRUG).
Who is sponsoring clinical trial NCT03043430?
This trial is sponsored by Brooke Army Medical Center, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03043430's enrollment target sits among peer trials
10 1940th of 2000 higher than 33 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia